Duchenne muscular dystrophy is a musculoskeletal disease caused by mutations in the dystrophin gene. The purpose of this study was to use the mouse model of muscular dystrophy (mdx) to determine if the progression of the dystrophic phenotype in the diaphragm (costal) versus limb skeletal muscle (tibialis anterior) is associated with specific changes in extracellular regulated kinase (ERK1/2), p70 S6 kinase (p70S6k), or p38 signaling pathways. The studies detected that consistent with an earlier dystrophic phenotype, phosphorylation of p70S6k is elevated by 40% in the diaphragm with no change in limb muscle. In addition, phosphorylation of p38 kinase was decreased by 33% in the mdx diaphragm muscle. Levels of ERK1/2 as well as phosphorylation states were elevated in the diaphragm and limb muscle of mdx mice compared with age-matched control muscles. These results indicate that distinct signaling pathways are differentially activated in skeletal muscle of mdx mice. The specificity of these responses, particularly in the diaphragm, provides insight for potential targets for blunting the progression of the muscular dystrophy phenotype.
HoffmanEP, BrownRHJr, KunkelLM. Dystrophin: the protein product of the Duchenne muscular dystrophy focus. Cell51: 919–928, 1987.
2.
PetrofBJ. The molecular basis of activity-induced muscle injury in Duchenne muscular dystrophy. Mol Cell Biochem179: 111–123, 1998.
3.
BulfieldG, SillerWG, WightPA, MooreKJ. X chromosome-linked muscular dystrophy (mdx) in the mouse. Proc Natl Acad Sci U S A81: 1189–1192, 1984.
4.
CoultonGR, MorganJE, PartridgeTA, SloperJC. The mdx mouse skeletal muscle myopathy: I. A histological, morphometric and biochemical investigation. Neuropathol Appl Neurobiol14: 53–70, 1988.
5.
LefaucheurJP, PastoretC, SebilleA. Phenotype of dystrophinopathy in old mdx mice. Anat Rec242: 70–76, 1995.
6.
DangainJ, VrbovaG. Muscle development in mdx mutant mice. Muscle Nerve7: 700–704, 1984.
7.
Dupont-VersteegdenEE, KatzMS, McCarterRJ. Beneficial versus adverse effects of long-term use of clenbuterol in mdx mice. Muscle Nerve18: 1447–1459, 1995.
8.
Dupont-VersteegdenEE, McCarterRJ. Differential expression of muscular dystrophy in diaphragm versus hindlimb muscles of mdx mice. Muscle Nerve15: 1105–1110, 1992.
9.
LouboutinJP, Fichter-GagnepainV, ThaonE, FardeauM. Morphometric analysis of mdx diaphragm muscle fibres. Comparison with hindlimb muscles. Neuromuscul Disord3: 463–469, 1993.
10.
StedmanHH, SweeneyHL, ShragerJB, MaguireHC, PanettieriRA, PetrofB, NarusawaM, LeferovichJM, SladkyJT, KellyAM. The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy. Nature352: 536–539, 1991.
11.
HackAA, CordierL, ShoturmaDI, LamMY, SweeneyHL, McNallyEM. Muscle degeneration without mechanical injury in sarcoglycan deficiency. Proc Natl Acad Sci U S A96: 10723–10728, 1999.
12.
RandoTA. The dystrophin-glycoprotein complex, cellular signaling, and the regulation of cell survival in the muscular dystrophies. Muscle Nerve24: 1575–1594, 2001.
13.
YangB, JungD, MottoD, MeyerJ, KoretzkyG, CampbellKP. SH3 domain-mediated interaction of dystroglycan and Grb2. J Biol Chem270: 11711–11714, 1995.
14.
CavaldesiM, MacchiaG, BarcaS, DefilippiP, TaroneG, PetrucciTC. Association of the dystroglycan complex isolated from bovine brain synaptosomes with proteins involved in signal transduction. J Neurochem72: 1648–1655, 1999.
15.
LangenbachKJ, RandoTA. Inhibition of dystroglycan binding to laminin disrupts the PI3K/AKT pathway and survival signaling in muscle cells. Muscle Nerve26: 644–653, 2002.
16.
ChenYW, ZhaoP, BorupR, HoffmanEP. Expression profiling in the muscular dystrophies: identification of novel aspects of molecular pathophysiology. J Cell Biol151: 1321–1336, 2000.
17.
TkatchenkoAV, Le CamG, LegerJJ, DechesneCA. Large-scale analysis of differential gene expression in the hindlimb muscles and diaphragm of mdx mouse. Biochim Biophys Acta1500: 17–30, 2000.
18.
TkatchenkoAV, PietuG, CrosN, Gannoun-ZakiL, AuffrayC, LegerJJ, DechenseCA. Identification of altered gene expression in skeletal muscles from Duchenne muscular dystrophy patients. Neuromuscul Disord11: 269–277, 2001.
OnoK, HanJ. The p38 signal transduction pathway: activation and function. Cell Signal12: 1–13, 2000.
21.
BaarK, EsserK. Phosphorylation of p70S6k correlates with increased skeletal muscle mass following resistance exercise. Am J Physiol Cell Physiol276: C120–C127, 1999.
22.
AdiS, WuNY, RosenthalSM. Growth factor-stimulated phosphorylation of Akt and p70(S6K) is differentially inhibited by LY294002 and Wortmannin. Endocrinology142: 498–501, 2001.
23.
MalikRK, ParsonsJT. Integrin-dependent activation of the p70 ribosomal S6 kinase signaling pathway. J Biol Chem271: 29785–29791, 1996.
HornbergerTA, HunterRB, KandarianSC, EsserKA. Regulation of translation factors during hindlimb unloading and denervation of skeletal muscle in rats. Am J Physiol Cell Physiol281: C179–C187, 2001.
NaderGA, EsserKA. Intracellular signaling specificity in skeletal muscle in response to different modes of exercise. J Appl Physiol90: 1936–1942, 2001.
29.
NaveBT, OuwensM, WithersDJ, AlessiDR, ShepherdPR. Mammalian target of rapamycin is a direct target for protein kinase B: identification of a convergence point for opposing effects of insulin and amino-acid deficiency on protein translation. Biochem J344: 427–431, 1999.
30.
ScottPH, BrunnGJ, KohnAD, RothRA, LawrenceJCJr.Evidence of insulin-stimulated phosphorylation and activation of the mammalian target of rapamycin mediated by a protein kinase B signaling pathway. Proc Natl Acad Sci U S A95: 7772–7777, 1998.
31.
BodineSC, StittTN, GonzalezM, KlineWO, StoverGL, BauerlineR, ZlotchenkoE, ScrimgeourA, LawrenceJC, GlassDJ, YancopoulosGD. Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo.Nature Cell Biol3:1014–1019, 2001.
32.
Dupont-VersteegdenEE. Exercise and clenbuterol as strategies to decrease the progression of muscular dystrophy in mdx mice. J Appl Physiol80: 734–741, 1996.
33.
PastoretC, SebilleA. mdx mice show progressive weakness and muscle deterioration with age. J Neurol Sci129: 97–105, 1995.
34.
HarperSJ, LoGrassoP. Signalling for survival and death in neurones: the role of stress-activated kinases, JNK and p38. Cell Signal13: 299–310, 2001.
35.
WangY, HuangS, SahVP, RossJJr, BrownJH, HanJ, ChienKR. Cardiac muscle cell hypertrophy and apoptosis induced by distinct members of the p38 mitogen-activated protein kinase family. J Biol Chem273: 2161–2168, 1998.
36.
MegeneyLA, KablarB, PerryRL, YingC, MayL, RudnickiMA. Severe cardiomyopathy in mice lacking dystrophin and MyoD. Proc Natl Acad Sci U S A96: 220–225, 1999.
37.
WidegrenU, RyderJW, ZierathJR. Mitogen-activated protein kinase signal transduction in skeletal muscle: effects of exercise and muscle contraction. Acta Physiol Scand172: 227–238, 2001.
38.
KhajaviM, TariAM, PatelNB, TsujiK, SiwakDR, MeistrichML, TerryNH, AshizawaT. “Mitotic drive” of expanded CTG repeats in myotonic dystrophy type 1 (DM1). Hum Mol Genet10: 855–863, 2001.
39.
LiM, DalakasMC. The muscle mitogen-activated protein kinase is altered in sporadic inclusion body myositis. Neurology54: 1665–1670, 2000.
40.
NakanoS, ShindeA, KawashimaS, NakamuraS, AkiguchiI, KimuraJ. Inclusion body myositis: expression of extracellular signal-regulated kinase and its substrate. Neurology56: 87–93, 2001.
41.
WilczynskiGM, EngelWK, AskanasV. Association of active extracellular signal-regulated protein kinase with paired helical filaments of inclusion-body myositis muscle suggests its role in inclusion-body myositis tau phosphorylation. Am J Pathol156: 1835–1840, 2000.
